Evidence map›Paper›PMID 40331237›Full record

ArticleNeurophotonics2025

Retinal changes detected by diffuse reflectance spectroscopy in parkinsonian monkeys.

Jonathan Munro, Elahe Parham, Damon DePaoli, Nicolas Lapointe, Cleophace Akitegetse, Shirley Fecteau, Dominic Sauvageau, Thérèse Di Paolo, Daniel C Côté, Martin Parent

Abstract read
In one paragraph

Article in Neurophotonics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonathan MunroUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0003-3432-7143
Elahe ParhamUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0003-2747-8744
Damon DePaoliUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.
Nicolas LapointeZilia Inc, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0002-2635-3790
Cleophace AkitegetseZilia Inc, Quebec City, Quebec, Canada.
Shirley FecteauUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0002-9781-4451
Dominic SauvageauZilia Inc, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0002-1995-5523
Thérèse Di PaoloUniversité Laval, CHU de Québec Research Center, Quebec City, Quebec, Canada.
Daniel C CôtéUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0001-6440-6948
Martin ParentUniversité Laval, CERVO Brain Research Center, Quebec City, Quebec, Canada.ORCID https://orcid.org/0000-0002-0868-1010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Parkinson's disease (PD) is diagnosed when 50% neurodegeneration has occurred. The retina could provide biomarkers that would allow for earlier diagnosis. Retinal spectroscopy is a technique that could be used to find such biomarkers. Aim: We aimed to find new diagnostic biomarkers for PD following detailed spectral examinations of the retina. Approach: The newly developed Zilia Ocular device was used to perform spectrometric scans of the optic nerve head (ONH) and the retina of four cynomolgus monkeys ( Results: The analysis of the DRS indicated a lower slope between the 480- and 525-nm wavelengths in both the ONH and the retina. Post-mortem measurements of the retinal layer thicknesses showed that the outer nuclear layer was significantly thinner in MPTP-intoxicated monkeys, compared with controls. Altogether, these results indicate that MPTP altered the optical properties of the ONH and the retina and show that these variations might be explained by MPTP-induced structural changes in the eye fundus, as observed post-mortem. Conclusions: Overall, our results indicate that spectroscopy could be used as a noninvasive method to detect changes in the retina that occur in PD and that such changes could represent retinal biomarkers for improved diagnosis.

Indexed as

biomarkersMPTPneurodegenerative diseasenonhuman primatesParkinson’s diseaseretina

Identifiers

PMID40331237
PMCPMC12052396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.